Hugel resubmits BLA for its botulinum toxin, Botulax to the U.S. FDA
Hugel received CRL from the U.S. FDA last March and completely supplemented documents and data. It is expected to obtain the U.S. FDA's approval in the first half of 2023 and aims to become a TOP 3 botulinum toxin brand in the U.S. market. SEOUL, South Korea, Oct. 7, 2022...
Raffles Medical Group and NalaGenetics Provide Pre-emptive Genetic Testing for Adverse Drug Reactions
Raffles is the first hospital in Singapore to provide pre-emptive pharmacogenomics testing protocol Aims to reduce side effects due to inappropriate medications SINGAPORE, Oct. 7, 2022 /PRNewswire/ -- Raffles Medical Group (RMG) is collaborating with biotech start-up NalaGenetics to offer pre-emptive pharmacogenomics testing at its hospital. It is the first hospital in Singapore to provide such a service....
Medit wins four consecutive patent lawsuits against 3Shape
SEOUL, South Korea, Oct. 7, 2022 /PRNewswire/ -- Medit Corp. ("Medit"), a global provider of 3D scanning solutions, has successfully defended against four separate patent infringement actions filed in Germany by a Danish competitor, 3Shape A/S ("3Shape"). Over the past 3 years, 3Shape has aggressively pursued patent infringement actions against Medit based...
Synapse Medicine Initiates Multi-Site Implementation Study with Leading U.S Hospitals
Synapse Medicine clinical decision support technology analyzes drug-related risks based on each patient's clinical characteristics and will be studied for its impact on inpatient pharmacist efficacy and efficiency. The Synapse Medicine medication reconciliation tool will be deployed through an integration with the hospitals' current EPIC EHR workflow. The study also has...
EVERISE NAMED TO NEWSWEEK’S LIST OF THE TOP 100 MOST LOVED WORKPLACES FOR 2022
Everise is Among the Top 100 U.S. Companies Recognized for Employee Sentiment and Satisfaction for the Second Year in a Row NEW YORK, Oct. 7, 2022 /PRNewswire/ -- Newsweek announced today their annual rankings for the Top 100 Most Loved Workplaces® list. Everise made the list once again and was ranked #90. The 2022...
United Imaging Installs Broward County’s First uMI 550 at Holy Cross Health in Fort Lauderdale
Holy Cross procured the uMI 550 to "go digital" and continue to innovate for its community. HOUSTON, Oct. 7, 2022 /PRNewswire/ -- United Imaging, a global manufacturer of medical imaging equipment, announced the installation of Broward County's first uMI 550 at Holy Cross Health, a member of Trinity Health, in Fort Lauderdale, Florida. United Imaging innovates and produces equipment...
TauRx Announces Results from Phase 3 Alzheimer’s Disease Study, LUCIDITY, Assuring Path for Regulatory Submissions
For people with early Alzheimer's (MCI), HMTM treatment resulted in sustained improvement in cognition over pre-treatment baseline, and normalisation of brain atrophy to a rate similar to healthy individuals For people with mild to moderate Alzheimer's, HMTM stabilised cognition and function and reduced rate of brain atrophy compared to historical matched individuals with AD HMTM is an oral...
AWARD-WINNING SKINPEN® PRECISION ANNOUNCES NEW AND EXPANDED APPROVED INDICATIONS
Solidifies Status as the Leading, Most Advanced Skin Remodeling Treatment System DALLAS, Oct. 6, 2022 /PRNewswire/ -- Crown Aesthetics ("Crown"), a division of Crown Laboratories and inventors of the award-winning SkinPen Precision, announced today that its revolutionary device has received three new approved indications, further strengthening its status as the most...
Cytiva strengthens cell line development with CEVEC acquisition
Viral vector manufacturing and cell line development are keystone technologies in the making of gene therapies 46 scientific experts based in Cologne, Germany, join the Cytiva team in the genomic medicine space Cytiva customers will have immediate access to technologies that solve some of the greatest challenges in bringing gene therapies to patients AMERSHAM, England, Oct. 6, 2022 /PRNewswire/ -- Global life sciences leader Cytiva has acquired CEVEC Pharmaceuticals, a leading German...
Servier unveils its 2030 ambition and reveals a new visual identity
A new ambition by 2030 to accelerate its transformation dynamic A visual identity, a marker of the successful transformation of the Group, its ambitions and its renewal PARIS, Oct. 6, 2022 /PRNewswire/ -- Servier today unveils its 2030 ambition as well as a new visual identity that reflects the transformation...
